hotspot -WSS

hotspot

author：focus 2025-09-04 22:01:42 - browse：454

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Violet CEO on training clinicians to promote more inclusive care

focus

WSS

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

SEC charges former device maker CEO with $41 million fraud

Juul documents reveal insider tactics on political lobbying

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Artificial intelligence use in health care faces greater scrutiny in 2024

Report cites 'urgent' need to recruit more diverse clinical trial participants

leisure time

hotspot

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

HCA sued by state AG for quality issues at Mission Health

Wildfire smoke exposes gaps in outdoor worker protections

Why don't Americans have at

Psychedelics group wrestles with new pharma identity

Keeping primary care docs in field isn't impossible, says AAFP CEO

Jerome Adams on the need for new antivirals for Covid

Doctors on social media are being harassed and cyberbullied

Bright Health sells Medicare Advantage business to Molina

Keeping primary care docs in field isn't impossible, says AAFP CEO

hotspot

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Why Eli Lilly’s earnings didn’t quite live up to the hype

Christmas in the PICU brings some surprising joy

Too many hospitalized Covid

Readout Newsletter: Amylyx, Aurinia, and IQVIA

HCA sued by state AG for quality issues at Mission Health

focus

knowledge

explore

hotspot